$ATNX

09.08.20 Secondary Announcement

This content is restricted to IPO Boutique Subscribers Username or Email Password Remember me Lost your password? Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry[…]

IPO Recap: Athenex up 25+% in opening week

SIGN UP FOR IPO BOUTIQUE’S FREE NEWSLETTER   Two IPOs came to market this week with mixed success.   Athenex Inc (Nasdaq: ATNX) priced a full-size deal at the low-end of the range, $11.00, and opened with a $1.00 premium at first trade. The heavily insider-backed offering traded well in its opening week as ‘ATNX’[…]

Athenex IPO Preview

Company: Athenex, Inc. Symbol: ATNX Description: They are a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Shares: 6 million Price Range: $11.00-$13.00 Trade Date: 6/14 Underwriter(s): Credit Suisse, Deutsche Bank Securities, J.P. Morgan Co-Manager: ICBC International Link to S-1/A Prospectus Investor Access: This deal[…]

Two Healthcare IPOs on tap for week ahead

This past week two IPOs debuted, one IPO updated terms and two new deals were filed. Two IPOs came to market with far different levels of success. ShotSpotter, Inc (Nasdaq: SSTI) priced 2.8mm shares at the midpoint of the range, $11.00, and opened 10.9% higher with a first trade of $12.20. The Roth Capital underwritten[…]

New Filings & Updated Terms – Week Ending 6.2.17

IPO Boutique keeps apprised of the active pipeline. Currently there are 61 active IPOs in the pipeline as of June 2, 2016. No SPACs or Unit Offerings are included.   NEW FILINGS Company: Byline Bancorp, Inc. Symbol: BY Description: They are a bank holding company headquartered in Chicago, Illinois and conduct all our business activities[…]

Scroll to top
error: Content is protected !!